France Labrèche1, Mark S Goldberg, Marie-France Valois, Louise Nadon. 1. Institut de recherche Robert-Sauvé en santé et en sécurité du travail du Québec, 505 boul. de Maisonneuve Ouest, Montréal, Québec, Canada H3A 3C2. france.labreche@irsst.qc.ca
Abstract
OBJECTIVE: To determine whether exposures in the workplace to organic solvents and to other agents, such as polycyclic aromatic hydrocarbons, are associated with increased risks of developing postmenopausal breast cancer. METHODS: Between 1996 and 1997 a case-control study was conducted in Montreal, Quebec. Cases comprised 556 women, aged 50-75 years, with incident malignant breast cancer, and their controls were 613 women with other cancers, frequency matched for age, date of diagnosis and hospital. An expert team of chemists and industrial hygienists translated their job histories into exposure to about 300 agents. RESULTS: Odds ratios (ORs) were increased for the usual risk factors for breast cancer and, adjusting for these, risks increased with occupational exposure to several agents, and were highest for exposures occurring before age 36 years. Increased ORs were found for each 10-year increment in duration of exposure, before age 36 years (OR(<36)), to acrylic fibres (OR(<36)=7.69) and to nylon fibres (OR(<36)=1.99). For oestrogen-positive and progesterone-negative tumours, the OR doubled or more for each 10-year increase in exposure to monoaromatic hydrocarbons, and to acrylic and rayon fibres. The OR(<36) also doubled for exposure to organic solvents that metabolise into reactive oxygen species, and to acrylic fibres. A threefold increase was found for oestrogen- and progesterone-positive tumours, with exposure to polycyclic aromatic hydrocarbons from petroleum sources. CONCLUSION: Certain occupational exposures appear to increase the risk of developing postmenopausal breast cancer, although some findings might be due to chance or to undetected bias. Our findings are consistent with the hypothesis that breast tissue is more sensitive to adverse effects if exposure occurs when breast cells are still proliferating. More refined analyses, adjusting for hormonal receptor subtypes and studies focusing on certain chemical exposures are required to further our understanding of the role of chemicals in the development of breast cancer.
OBJECTIVE: To determine whether exposures in the workplace to organic solvents and to other agents, such as polycyclic aromatic hydrocarbons, are associated with increased risks of developing postmenopausal breast cancer. METHODS: Between 1996 and 1997 a case-control study was conducted in Montreal, Quebec. Cases comprised 556 women, aged 50-75 years, with incident malignant breast cancer, and their controls were 613 women with other cancers, frequency matched for age, date of diagnosis and hospital. An expert team of chemists and industrial hygienists translated their job histories into exposure to about 300 agents. RESULTS: Odds ratios (ORs) were increased for the usual risk factors for breast cancer and, adjusting for these, risks increased with occupational exposure to several agents, and were highest for exposures occurring before age 36 years. Increased ORs were found for each 10-year increment in duration of exposure, before age 36 years (OR(<36)), to acrylic fibres (OR(<36)=7.69) and to nylon fibres (OR(<36)=1.99). For oestrogen-positive and progesterone-negative tumours, the OR doubled or more for each 10-year increase in exposure to monoaromatic hydrocarbons, and to acrylic and rayon fibres. The OR(<36) also doubled for exposure to organic solvents that metabolise into reactive oxygen species, and to acrylic fibres. A threefold increase was found for oestrogen- and progesterone-positive tumours, with exposure to polycyclic aromatic hydrocarbons from petroleum sources. CONCLUSION: Certain occupational exposures appear to increase the risk of developing postmenopausal breast cancer, although some findings might be due to chance or to undetected bias. Our findings are consistent with the hypothesis that breast tissue is more sensitive to adverse effects if exposure occurs when breast cells are still proliferating. More refined analyses, adjusting for hormonal receptor subtypes and studies focusing on certain chemical exposures are required to further our understanding of the role of chemicals in the development of breast cancer.
Authors: Jean-François Sauvé; Jack Siemiatycki; France Labrèche; Lesley Richardson; Javier Pintos; Marie-Pierre Sylvestre; Michel Gérin; Denis Bégin; Aude Lacourt; Tracy L Kirkham; Thomas Rémen; Romain Pasquet; Mark S Goldberg; Marie-Claude Rousseau; Marie-Élise Parent; Jérôme Lavoué Journal: Ann Work Expo Health Date: 2018-08-13 Impact factor: 2.179
Authors: Aude Lacourt; France Labrèche; Mark S Goldberg; Jack Siemiatycki; Jérôme Lavoué Journal: Ann Work Expo Health Date: 2018-11-12 Impact factor: 2.179
Authors: Christine C Ekenga; Christine G Parks; Aimee A D'Aloisio; Lisa A DeRoo; Dale P Sandler Journal: Cancer Res Date: 2014-06-01 Impact factor: 12.701
Authors: Donald A Fleming; Susan R Woskie; James H Jones; Sharon R Silver; Lian Luo; Stephen J Bertke Journal: J Occup Environ Hyg Date: 2014 Impact factor: 2.155
Authors: James T Brophy; Margaret M Keith; Andrew Watterson; Robert Park; Michael Gilbertson; Eleanor Maticka-Tyndale; Matthias Beck; Hakam Abu-Zahra; Kenneth Schneider; Abraham Reinhartz; Robert Dematteo; Isaac Luginaah Journal: Environ Health Date: 2012-11-19 Impact factor: 5.984
Authors: Derrick G Lee; Johanna M Schuetz; Agnes S Lai; Igor Burstyn; Angela Brooks-Wilson; Kristan J Aronson; John J Spinelli Journal: Breast Cancer Date: 2021-08-05 Impact factor: 4.239